Flagship Pioneering reposted this
We announced today that the European Commission has granted marketing authorization for our mRNA respiratory syncytial virus (RSV) vaccine. The marketing authorization follows the Positive Opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). Read more: https://lnkd.in/e6rDu_zs
Congratulations on the marketing authorization for the mRNA respiratory syncytial virus (RSV) vaccine! Your dedication to advancing medical solutions is truly commendable.
Great news for patients. You only need to see the distress RSV causes to the most vulnerable to recognise this vaccine is long overdue. Well done Moderna
Landmark achievement…
Amazing, and with the updated Covid vaccine, fall will be more bearable thanks for innovation from biotechnology!
Congratulations on the marketing authorization in Europe for your mRNA respiratory syncytial virus vaccine, Moderna! Your dedication to innovation and healthcare is truly commendable.
You guys making anything that stops programmed cell death from your first Covid booster ?🤔
Congratulations to the whole team; a major achievement
Congrats.......!!! Proud to have worked with this great team since pre-IPO days. Amazing Feat!!!
As somone who has lost loved ones to respiratory disease I value this advance by Moderna. At Omniscope we characterise immune response to vaccines and infections. https://www.omniscope.ai/recordings/longitudinal-covid-19-case-study-by-dr-christian-brander